Discovery & Pre/Clinical Sciences

NIBR has built expertise around several key technology competencies. Each competency combines automation and robotics, computational science, biology and irreplaceable drug discovery knowledge. By building expertise around key technologies, it can be more effectively applied across diseases that share similar mechanisms.

 

Analytical Sciences ›
Supportings drug discovery through analytical expertise

 

Biologics ›
Taking the lead in biotechnology

 

Biomarker Development ›
Accelerating drug development with biomarkers

 

Chemistry ›
Designing and creating potential new drugs

 

DMP ImageDevelopmental & Molecular Pathways ›
Understanding and modulating signal transduction networks involved in disease 

 

Drug Metabolism & Pharmacokinetics ›
Optimizing the performance of a new drug

 

Friedrich Miescher Institute for Biomedical Research ›
Devoted to fundamental biomedical research and focuses on epigenetics, growth control and neurobiology

 

Genomics Institute of the Novartis Research Foundation ›
Developing advanced technologies, ranging from cellular genomics and proteomics to combinatorial chemistry and structural biology

 

Imaging ›
Adding substance to pharmaceutical discovery

 

Metabolism & Pharmacokinetics ›
Predicting how drug leads will behave in the body

 

Preclinical Safety ›
Focusing on drug safety is Priority 1

 

Proteomic Chemistry ›
Studying the interaction of chemistry and biology

 

Translational Medicine ›
Translating biology into medicine